Sarkis K Mazmanian, California Institute of Technology

34
Sarkis K Mazmanian, California Institute of Technology

Transcript of Sarkis K Mazmanian, California Institute of Technology

Sarkis K Mazmanian, California Institute of Technology

•The human gut harbors 1011-1012 bacteria per gram colonic content

(>1014 total bacteria)

•Total bacteria outnumber human cells 10:1

•Total bacterial genes outnumber human genes >100:1

•>1,000 different species of bacteria are resident in the human

intestinal microbiota (400-500 per person)

The human microbiota

Lee & Mazmanian, Science (2010)

•Antibiotics ameliorate symptoms in

humans and animals

•Germ-free animals do no develop IBD

in several models

•No definitive pathogens identified

•Immune reactivity to commensal

organisms

•Alterations in the microbiota of IBD

patients

•Predicted defects in immune regulation

Bacteria play a critical role in

inflammatory bowel disease (IBD)

The human gastrointestinal tract is

populated by both harmful and beneficial bacteria

Pederson D, Cell Host & Microbe (2008)

•Bacteroides fragilis is a gram-negative, obligate anaerobic bacteria

•B. fragilis synthesizes at least eight unique capsular

polysaccharide complexes from distinct genomic loci

•At least two of these polysaccharides (PSA and PSB) have a

novel zwitterionic structure (both a positive and negative charge

within each repeating subunit)

•B. fragilis is a prominent commensal of in the human GI tract

Polysaccharide A (PSA)

Mazmanian et al, Cell (2005)

PSA protects from chemically induced

intestinal inflammation

Mazmanian et al, Nature (2008)

Colitis is driven pro-inflammatory T-helper cells and

elevated IL-17/IL-23 levels

Neurath, M, Nature Medicine (2007)

Colitis

PSA mediates the expansion of functionally suppressive

CD4+CD25+Foxp3+ Tregs during TNBS colitis

Round et al., PNAS (2010)

Protection from TNBS colitis by PSA requires

Toll-like receptor 2 signaling

PSA is packaged into outer membrane vesicles (OMVs)

Shen et al., (submitted)

OMVs protect mice from colitis in a PSA-dependent manner

OMVs protect mice from colitis in a PSA-dependent manner

Gene expression profile of PSA-specific and TLR2

dependent genes in dendritic cells

Gadd45a expression in dendritic cells is required for PSA-

mediated protection from colitis

Gadd45a expression in dendritic cells is required for PSA-

mediated protection from colitis

PSA of B. fragilis prevents pro-inflammatory immune

responses in the gut to protect from colitis

Gadd45a

PSA of B. fragilis prevents pro-inflammatory immune

responses in the gut to protect from colitis

Gadd45a

Is there a role for PSA during homeostasis?

Conventional Germ-free B. fragilis B. fragilisPSA

CD

4

IL17A

7.65 0.73 1.46 4.48

% C

D4

+IL

-17A

+ 15

10

5

0 0

5

10

15 *** ***

Round et al., Science (2011)

PSA restrains Th17 responses to B. fragilis

Foxp3

CD

4

1.99 0.06

-DT +DT

0

1

2

3

4

5

6

7

- DT +DT

*** 10

5

0 IL-17A

CD

4

21 3.1 37 6.2

-DT +DT (-Tregs)

0.7 0.9

% IL

-17A

+

Foxp3-DTR mice with B. fragilis

Conventional Germ-free B. fragilis B. fragilisPSA

CD

4

IL17A

7.65 0.73 1.46 4.48

% C

D4

+IL

-17A

+ 15

10

5

0 0

5

10

15 *** ***

Round et al., Science (2011)

PSA restrains Th17 responses to B. fragilis

Foxp3

CD

4

1.99 0.06

-DT +DT

0

1

2

3

4

5

6

7

- DT +DT

*** 10

5

0 IL-17A

CD

4

21 3.1 37 6.2

-DT +DT (-Tregs)

0.7 0.9

% IL

-17A

+

Foxp3-DTR mice mono-colonized with B. fragilis

Toll-like receptors on innate cells activate T cells

Toll-like receptors on innate cells activate T cells

TLR2 expression on CD4+ T cells is required for

in vitro IL-10 production by PSA

TLR2 expression on CD4+ T cells is required for

in vitro IL-10 production by PSA

PSA is required for efficient mucosal colonization

of germ-free mice by B. fragilis

Germ-free

B. fragilis

mono-colonized B. fragilis

mono-colonized

rel. u

nits

a

CF

U/g

1010

106

102

Colon Lumen

PSA is required for efficient mucosal colonization

of germ-free mice by B. fragilis

Germ-free

B. fragilis

mono-colonized B. fragilis

mono-colonized

re

l. u

nits

-DT +DT

(-Tregs)

10

5

0

15

1,0E+00

1,0E+01

1,0E+02

1,0E+03

1,0E+04

1,0E+05

1,0E+06

1,0E+07

1,0E+08

1,0E+09

1,0E+10

1,0E+11

CF

U

-DT +DT

Colon Lumen

Germ-free mice with B. fragilis

PSA signals through TLR2 on Tregs to suppress Th17 cell

responses during mucosal colonization by B. fragilis

Iso α-IL-17A

rel. u

nits

Iso α-IL-17A 1.01003

1.01004

1.01005

1.01006

1.01007

1.01008

108

106

104

30

20

10

0

re

l. u

nits

-DT +DT

(-Tregs)

10

5

0

15

1,0E+00

1,0E+01

1,0E+02

1,0E+03

1,0E+04

1,0E+05

1,0E+06

1,0E+07

1,0E+08

1,0E+09

1,0E+10

1,0E+11

CF

U

-DT +DT

Colon Lumen

B. fragilis

B. fragilis

PSA

WT CD4+ Tlr2-/- CD4+ 0

5

10

15

20

25

30

35

40

rel. u

nits 40

50 Colon

CF

U/g

Colon

Germ-free mice with B. fragilisPSA

Germ-free mice with B. fragilis

PSA signals through TLR2 on Tregs to suppress Th17 cell

responses during mucosal colonization by B. fragilis

PSA evolved to promote mucosal tolerance during

commensal colonization by Bacteroides fragilis

TLR2

WT B. fragilis

Gadd45a

PSA evolved to promote mucosal tolerance during

commensal colonization by Bacteroides fragilis

TLR2

WT B. fragilis

B. fragilisPSA

Bach JF, NEJM, 2002

The inverse correlation between infectious diseases

and human inflammatory disorders

Bach JF, NEJM, 2002

The inverse correlation between infectious diseases

and human inflammatory disorders

Bach JF, NEJM, 2002

The inverse correlation between infectious diseases

and human inflammatory disorders

Regulatory T cells protect against these diseases in mice

Potential causes of dysbiosis due to ‘western’ lifestyles

its role in intestinal health and disease

Genetics and Environment

Round & Mazmanian, Nature Rev Immunol (2009)

June Round (Utah) Yue Shen Janet Chow Melanie Lee Jennifer Li Yun Kyung Lee Arya Khosravi Haiqing Tang Huitung Chu Gil Sharon Sara McBride Katie Schretter Gregory Donaldson Talal Chatila (UCLA) Bana Jabri (UChicago) Jonathan Ashwell (NIH) Alexander Rudensky (MSKCC) Lora Hooper (UT Southwestern)